2 Generic Drug Stocks Ready to Surge in 2025
Viatris Inc.
WKN: A2QAME / Symbol: VTRS / Name: Viatris / Aktie / Pharmazeutika / Mid Cap /
13,63 €
2,45 %
2 Generic Drug Stocks Ready to Surge in 2025
Generic and biosimilar drugs are often preferred over the brand name version due to their cheaper prices. Generics are exact duplicates of the branded counterparts, while biosimilars are "similar"
By the end of the year, the new product revenue estimate was increased from $500 million to $600 million watermelon game . The day after its profits were released, shares jumped 13%.
Neueste Beiträge
juliamaribell in 5 Countries Where Casino Stock Investments Make Strong Sense, travel BV ADR